Bladder cancer: 2017 and beyond

por Kamat, Ashish M.
Publicado en Indian J Urol (2017)

Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease

por Kamat, Ashish M.
Publicado en Eur Urol (2021)

Myths and Mysteries Surrounding Bacillus Calmette-Guérin Therapy for Bladder Cancer

por Kamat, Ashish M., Orten, Sima
Publicado en Eur Urol (2013)

Advances in risk stratification of bladder cancer to guide personalized medicine

por Matulay, Justin T., Kamat, Ashish M.
Publicado en F1000Res (2018)

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

por Gupta, Shilpa, Kamat, Ashish M.
Publicado en Nat Rev Urol (2020)

Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

por Gupta, Shilpa, Kamat, Ashish M.
Publicado en Nat Rev Urol (2020)

Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer

por Agarwal, Piyus K., Kamat, Ashish M.
Publicado 2008

Optimal timing of chemotherapy and cystectomy

por Karam, Jose A, Kamat, Ashish M
Publicado 2010

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination

por Jinesh G., Goodwin, Kamat, Ashish M.
Publicado 2012

RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program

por Jinesh, Goodwin G, Kamat, Ashish M
Publicado en Cell Death Discov (2017)

Strategies to minimize readmission rates following major urologic surgery

por Baack Kukreja, Janet, Kamat, Ashish M.
Publicado en Ther Adv Urol (2017)

What is new in non-muscle-invasive bladder cancer in 2016?

por Kamat, Ashish M., Bağcıoğlu, Murat, Huri, Emre
Publicado en Turk J Urol (2017)

Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL

por Jinesh G., Goodwin, Chunduru, Srinivas, Kamat, Ashish M.
Publicado 2012

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

por Li, Roger, Gilbert, Scott M., Kamat, Ashish M.
Publicado en Eur Urol (2020)

Genetic Variations in Regulator of G-Protein Signaling (RGS) Confer Risk of Bladder Cancer

por Lee, Eugene K., Ye, Yuanquing, Kamat, Ashish M., Wu, Xifeng
Publicado 2013

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease

por Li, Roger, Sylvester, Richard, Dinney, Colin P., Kamat, Ashish M.
Publicado en Bladder Cancer (2017)

Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?

por O'Connor, Ellen, Teh, Jiasian, Kamat, Ashish M, Lawrentschuk, Nathan
Publicado en Future Oncol (2020)

In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy

por Taoka, Rikiya, Williams, Stephen B., Ho, Philip L., Kamat, Ashish M.
Publicado en Can Urol Assoc J (2015)

Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo()

por Jinesh, Goodwin G., Lee, Eugene Kang, Tran, Jonathan, Kamat, Ashish M.
Publicado en Urol Oncol (2012)

Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients

por Li, Roger, Amrhein, John, Cohen, Zvi, Champagne, Monique, Kamat, Ashish M.
Publicado en Bladder Cancer (2017)